Chroma Medicine

HQ: Cambridge, MA, USACEO: Catherine Stehman-BreenHeadcount: 100+chromamedicine.com ↗

Funding Summary

Total Funding

$260M+

Latest Valuation

Undisclosed

About

Pioneering epigenome editing — silencing or activating genes without cutting DNA by modifying epigenetic marks, avoiding permanent DNA changes.

platform Programs

Chroma Medicine is pioneering epigenome editing, a next-generation approach that...

Recent Developments

Recent developments are auto-populated from tagged articles in the Newsfeed. Browse all news →

Referenced In